Corient Private Wealth
AORT icon

Corient Private Wealth’s Artivion AORT Stock Holding History

Corient Private Wealth’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.58M Buy
+159,348
New +$4.46M 0.01% 1039

Other funds holding AORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Corient Private Wealth's AORT Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Artivion (AORT) in Q2 2026: 159,348 shares worth $3.58M. The stake represents 0.01% of the portfolio and ranks #1039 among its holdings.

206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Corient Private Wealth held 159,348 shares of Artivion worth $3.58M as of Q2 2026.
  • Artivion was a new Corient Private Wealth position in Q2 2026.
  • Artivion made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1039 holding.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.